CD70 / TNFSF7 (Activated T- & B-Lymphocyte Marker) Antibody

Biorbyt

CD70 / TNFSF7 (Activated T- & B-Lymphocyte Marker) Antibody

10

Positive Control: Raji cells. Lymph node or tonsil. ELISA (For coating, order Ab without BSA); ,Inhibits T cell proliferation induced by dendritic cells (Order Ab without Azide); ,Flow Cytometry (1-2ug/million cells); Immunofluorescence (1-2ug/ml); ,Immunoprecipitation (1-2ug/500ug protein lysate); ,Immunohistochemistry (Frozen) (1-2ug/ml for 30 minutes at RT),Optimal dilution for a specific application should be determined. ELISA, FC, IF, IHC

Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry

Research Use Only

Monoclonal

BU69

1.0 mg/ml

Unconjugated

CD70

CD70 molecule

CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A, CD70 antigen, CD27 ligand, Ki-24 antigen, surface antigen CD70, tumor necrosis factor ligand 8A, tumor necrosis factor ligand superfamily member 7

Mouse

IgG1

CD70 antigen

CD70 / TNFSF7 (Activated T- & B-Lymphocyte Marker) Antibody

Human

-20°C,2°C to 8°C

12352203